Literature DB >> 1800375

Water- and airborne Francisella tularensis biovar palaearctica isolated from human blood.

T Hoel1, O Scheel, S H Nordahl, T Sandvik.   

Abstract

The isolation of Francisella tularensis from human blood is extremely rare in Europe. We here describe two cases of septicemia caused by F. tularensis biovar palaearctica, where the causative bacterium was isolated from blood. One of our patients had ingested contaminated water; the other was probably infected by inhalation of contaminated dust. The isolation of the causative organism was essential for initiating the appropriate antibiotic treatment, which led to a rapid improvement. Since the responsive agent rarely is isolated from tularemia patients, blood cultures should be drawn more often in order to improve the diagnostic procedures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1800375     DOI: 10.1007/BF01645366

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  An epidemic of tularemia in Sweden during the summer of 1967.

Authors:  K E Myrbäck; O Ringertz; S Dahlstrand
Journal:  Acta Pathol Microbiol Scand       Date:  1968

2.  Airborne tularemia in Sweden.

Authors:  S Dahlstrand; O Ringertz; B Zetterberg
Journal:  Scand J Infect Dis       Date:  1971

3.  Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia.

Authors:  L Bevanger; J A Maeland; A I Naess
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

Review 4.  Tularemia: a 30-year experience with 88 cases.

Authors:  M E Evans; D W Gregory; W Schaffner; Z A McGee
Journal:  Medicine (Baltimore)       Date:  1985-07       Impact factor: 1.889

5.  Isolation of Francisella tularensis from blood.

Authors:  J M Provenza; S A Klotz; R L Penn
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Airborne transmission of tularemia in farmers.

Authors:  H Syrjälä; P Kujala; V Myllylä; A Salminen
Journal:  Scand J Infect Dis       Date:  1985

7.  Cellular fatty acid composition of Francisella tularensis.

Authors:  E Jantzen; B P Berdal; T Omland
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

8.  Isolation of Francisella tularensis biovar palaearctica from human blood.

Authors:  A Tärnvik; C Henning; E Falsen; G Sandström
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

  8 in total
  9 in total

1.  Treatment of tularemia with ciprofloxacin.

Authors:  O Scheel; R Reiersen; T Hoel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Francisella tularensis bacteremia.

Authors:  X Haristoy; A Lozniewski; C Tram; D Simeon; L Bevanger; C Lion
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

3.  Early recognition of atypical Francisella tularensis strains lacking a cysteine requirement.

Authors:  K Bernard; S Tessier; J Winstanley; D Chang; A Borczyk
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

4.  Characterization of two unusual clinically significant Francisella strains.

Authors:  J E Clarridge; T J Raich; A Sjösted; G Sandström; R O Darouiche; R M Shawar; P R Georghiou; C Osting; L Vo
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

5.  Binding and activation of host plasminogen on the surface of Francisella tularensis.

Authors:  Shawn R Clinton; James E Bina; Thomas P Hatch; Michael A Whitt; Mark A Miller
Journal:  BMC Microbiol       Date:  2010-03-12       Impact factor: 3.605

Review 6.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

7.  Francisella tularensis peritonitis in stomach cancer patient.

Authors:  Xiang Y Han; Linus X Ho; Amar Safdar
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

8.  The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Authors:  Tina Guina; Lynda L Lanning; Kristian S Omland; Mark S Williams; Larry A Wolfraim; Stephen P Heyse; Christopher R Houchens; Patrick Sanz; Judith A Hewitt
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

9.  Severe infections due to Francisella tularensis ssp. holarctica in solid organ transplant recipient: report of two cases and review of literature.

Authors:  Olivier Bahuaud; Cécile Le Brun; Thomas Chalopin; Marion Lacasse; Julien Le Marec; Clémence Pantaleon; Charlotte Nicolas; Louise Barbier; Louis Bernard; Adrien Lemaignen
Journal:  BMC Infect Dis       Date:  2019-03-08       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.